Columbia University
đşđ¸United States
- Country
- đşđ¸United States
- Ownership
- Private
- Established
- 1754-01-01
- Employees
- 20.8K
- Market Cap
- -
Nitrous Oxide Analgesia Vaso-occlusive Crisis
Phase 2
Terminated
- Conditions
- Sickle Cell DiseaseVaso-occlusive Crisis
- Interventions
- Drug: Nitrous oxide 50%
- First Posted Date
- 2013-07-03
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 5
- Registration Number
- NCT01891812
- Locations
- đşđ¸
New York Presbyterian Morgan Stanley Children's Hospital, New York, New York, United States
Swaziland Safe Generations
Completed
- Conditions
- HIV/AIDS
- Interventions
- Other: Option B+
- First Posted Date
- 2013-07-03
- Last Posted Date
- 2018-02-12
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 2518
- Registration Number
- NCT01891799
- Locations
- đ¸đż
Good Shepherd Hospital, Siteki, Lubombo, Swaziland
đ¸đżSiphofaneni, Siteki, Lubombo, Swaziland
đ¸đżMankayane PHU, Manzini, Swaziland
Start TB Patients on ART and Retain on Treatment (START Study)
Not Applicable
Completed
- Conditions
- HIVTuberculosis
- Interventions
- Other: Combination Intervention PackageOther: Standard of Care
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2021-07-14
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 415
- Registration Number
- NCT01872390
- Locations
- đąđ¸
Berea Hospital, Teyateyaneng, Lesotho
đąđ¸St. Theresa Health Center, Teyateyaneng, Lesotho
đąđ¸Koali Health Center, Koali, Lesotho
Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Withdrawn
- Conditions
- Chronic Fatigue Syndrome
- Interventions
- Drug: Nutraceuticals
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Columbia University
- Registration Number
- NCT01872351
- Locations
- đşđ¸
Columbia University Medical Center, New York, New York, United States
Drug User Internet and Mobile Tech Use
Not Applicable
Completed
- Conditions
- Drug Abuse Illicit
- Interventions
- Other: Pilot Website Evaluation Component
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 212
- Registration Number
- NCT01871298
- Locations
- đşđ¸
Columbia University Medical Center, New York, New York, United States
Using Multimedia Technologies to Disseminate an HIV Prevention
Not Applicable
Completed
- Conditions
- HIV Infection
- Interventions
- Behavioral: Multimedia ConnectBehavioral: Traditional Connect
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 253
- Registration Number
- NCT01863537
- Locations
- đşđ¸
Columbia University Social Intervention Group, New York, New York, United States
Evaluating a Microfinance Intervention for High Risk Women in Mongolia
Not Applicable
Completed
- Conditions
- HIV Infection
- Interventions
- Behavioral: HIV Sexual Risk reductionBehavioral: HIV Sexual Risk reduction plus Microfinance
- First Posted Date
- 2013-05-23
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 107
- Registration Number
- NCT01861431
- Locations
- đ˛đł
Aira Toivgoo, co-PI, Ulaanbaatar,, Mongolia
The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant
Completed
- Conditions
- ObesityContraception
- First Posted Date
- 2013-05-16
- Last Posted Date
- 2014-04-14
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 52
- Registration Number
- NCT01855620
- Locations
- đşđ¸
Columbia University Medical Center, New York, New York, United States
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Phase 2
Terminated
- Conditions
- NeuropathyBreast CancerColon Cancer
- Interventions
- Drug: placebo lotionDrug: topical menthol
- First Posted Date
- 2013-05-16
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 12
- Registration Number
- NCT01855607
- Locations
- đşđ¸
Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Phase 2
Completed
- Conditions
- Locally Advanced Malignant NeoplasmBreast Cancer
- Interventions
- Drug: PropranololOther: DOT imagingDrug: PaclitaxelDrug: Nab-paclitaxelDrug: TrastuzumabDrug: PertuzumabDrug: DoxorubicinDrug: CyclophosphamideProcedure: SurgeryDrug: PremedicationDrug: Anti-nausea therapyDrug: Pegfilgrastim
- First Posted Date
- 2013-05-06
- Last Posted Date
- 2021-09-10
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 10
- Registration Number
- NCT01847001
- Locations
- đşđ¸
Columbia University Irving Medical Center, New York, New York, United States
Š Copyright 2025. All Rights Reserved by MedPath